Imaginis.com Breast Health Newsletter | Newsletter 2000 | Imaginis - The Women's Health & Wellness Resource Network

The Women's Health Resource. On the web since 1997.

Imaginis.com Breast Health Newsletter


IMAGINIS BREAST HEALTH NEWSLETTER
VOLUME 2, ISSUE 25
NOVEMBER 2, 2000

Thousands of breast cancer patients, survivors and healthcare professionals receive the Imaginis.com Breast Health Newsletter, which is now published by email every week. If you would like to add the email addresses of your friends and family to the newsletter mailing list, please visit
http://www.imaginis.com/newsletter/

If you have questions, comments or suggestions regarding this newsletter or about your subscription status, please email us at
mailto:breasthealth@imaginis.com

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++

SIEMENS PROUDLY SPONSORS IMAGINIS.COM

Through its proud sponsorship of Imaginis.com, Siemens is dedicated to providing comprehensive information and service to improve and advance women's health. To learn more about Siemens involvement in women's health, please visit http://www.imaginis.com/siemens/

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++

BREAST HEALTH NEWS

1. PRESIDENT CLINTON SIGNS BREAST AND CERVICAL CANCER TREATMENT ACT
On October 24, President Clinton signed the Breast and Cervical Cancer Prevention and Treatment Act of 2000. The legislation provides funding for the screening and treatment of breast and cervical cancers for low-income women through the Centers for Disease Control's (CDC) National Breast and Cervical Cancer Early Detection Program.
Click here to read more:
http://www.imaginis.com/breasthealth/news/news10.30.00.asp

2. NEW TEST SHOWS PROMISE AS QUICK WAY TO IDENTIFY WOMEN WITH GENETIC BREAST AND OVARIAN CANCER RISK
Researchers have finished a preliminary study of a fast, inexpensive test to determine which women may have a genetic predisposition to breast or ovarian cancer.   The test analyzes cells taken from the inside of a woman's cheek (buccal cells) to determine whether she is carrying mutations of BRCA1 (breast cancer gene 1) or BRCA2 (breast cancer gene 2). Genetic mutations account for approximately 5% to 10% of breast and ovarian cancer cases. While larger studies of the cheek swab test are still needed before it becomes more common, the researchers say the preliminary results show great potential as an inexpensive genetic screening tool.
Click here to read more:
http://www.imaginis.com/breasthealth/news/news10.27.00.asp

3. YOU'VE HEARD OF THE CAT SCAN? NOW, HERE'S THE DOG SCAN: CANINE HELPS WITH CANCER DETECTION
Dogs have been trained to detect bombs, sniff out drugs, and even smell gas leaks in pipelines 20 feet below the ground. But can canines detect cancer? Well, in Tallahassee, Florida, a 43-pound  Standard Schnauzer police canine named George has been trained to successfully detect melanoma (a type of skin cancer) on humans. In one case, George pointed out a mole that had previously been examined by three different doctors and biopsied twice. After doctors finally removed the lesion and sent it to the pathology laboratory for a cell-by-cell analysis, they discovered that the patient had Stage II melanoma. If the mole had been left alone for another year, the patient could very well have died from skin cancer.
Click here to read more:
http://www.imaginis.com/breasthealth/news/news10.25.00.asp

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++

VISIT THE NEW IMAGINIS BOOKSTORE FOR PATIENTS AND PROFESSIONALS

The newly redesigned Imaginis Bookstore contains over 130 titles on breast health, breast cancer, medical imaging, and other women's health topics. The bookstore is divided into two sections, one for patients and the other for healthcare professionals. The books in the patient bookstore have been written for the general public and cover all aspects of breast cancer and related health topics. The healthcare professional section contains books written specifically for physicians, nurses, medical imaging technologists, and other healthcare professionals.
Click here to visit the bookstore:
http://www.imaginis.com/bookstore/

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++

BREAST HEALTH / BREAST CANCER INFORMATION

1. INTRODUCTION TO BREAST BIOPSY
A breast biopsy involves removing a sample of breast tissue to determine whether it is cancerous or benign (non-cancerous). While physical breast exam, mammography, ultrasound, and other breast imaging methods can help detect a breast abnormality, a biopsy (followed by microscopic analysis of the breast cells) is the only definitive way to determine if cancer is present. This fully revised and updated section introduces the topic of breast biopsy, and provides links to comprehensive information on the different methods of biopsy, how biopsy is performed, the benefits and risks of biopsy, who performs biopsy, understanding the results of biopsy, and more.
Click here to read more:
http://www.imaginis.com/breasthealth/biopsy/

2. T-SCAN BREAST IMAGING
T-scan is a new breast imaging exam that has recently been approved by the U.S. FDA to be used as a supplement to mammography in helping to detect breast cancer. T-scan uses the electrical impedance principal to measure the way electrical current passes through breast tissue and helps detect cancerous tumors. Conversely, T-scan imaging can also confirm when tumor tissue is benign (non-cancerous). Currently, T-scan is only available at approximately 35 facilities worldwide. As T-scan becomes more widely available, it may help to accurately diagnose more breast cancers in women. This section discusses all aspects of T-scan imaging.
Click here to read more:
http://www.imaginis.com/t-scan/

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++

IMAGINIS PATIENT AND PROFESSIONAL DISCUSSIONS

The Imaginis Discussions have been designed to help promote the discussion of a variety of women's health topics, including breast cancer, medical imaging and related health topics. The Patient Discussions are designed to bring women together who have shared similar experiences. Breast cancer patients, survivors, and all women interested in breast health issues are encouraged to participate in the Patient Discussions. In addition, Imaginis has recently added a Professional Discussion section to bring physicians and other healthcare providers together to discuss the latest women's health issues.
Click here to visit the Imaginis Discussions:
http://www.imaginis.com/discussions/

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++

HAVING TROUBLE ACCESSING THE LINKS IN THIS NEWSLETTER?

To view the full articles, click on the hyper-links following each summary. AOL (America Online) users may need to copy and paste the hyper-links in this newsletter into the web browser to view them. In some cases, the hyper-links following the summaries may not successfully retrieve the webpages if the address extends to more than one line. If this occurs, please copy the full text of the address and paste it into the address box in a web browser. Please note, Imaginis does not send "spam" email and will unsubscribe anyone upon request (see link below).

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++

MEDICAL DISCLAIMER: INFORMATION IN THIS NEWSLETTER, WITHIN THE IMAGINIS.COM WEBSITE OR IN OTHER SITES LINKED TO FROM THE IMAGINIS.COM WEBSITE SHOULD NOT BE USED FOR SELF-TREATMENT. THE INFORMATION FOUND IN THIS NEWSLETTER, IN THE IMAGINIS.COM WEBSITE AND IN WEBSITES LINKED TO FROM THE IMAGINIS.COM WEBSITE SHOULD BE USED FOR EDUCATIONAL PURPOSES ONLY AND IS NOT INTENDED TO BE USED AS A SUBSTITUTE FOR DIAGNOSIS AND TREATMENT BY A MEDICAL DOCTOR. USE OF THIS NEWSLETTER IS SUBJECT TO THE TERMS AND CONDITIONS OF USE FOUND ON IMAGINIS.COM AT http://www.imaginis.com/guestbook/agreement.asp .
IMAGINIS.COM DOES NOT ENDORSE AND HAS NO RESPONSIBILITY FOR THE CONTENT OF ANY OTHER SITES LISTED ON IMAGINIS.COM, AND PROVIDES LINKS AND REFERENCES MERELY AS A CONVENIENCE TO ITS USERS. SEEK IMMEDIATE MEDICAL ATTENTION IF YOUR CONDITION IS URGENT.